NCT02792335View on ClinicalTrials.gov

Oral Anticoagulant Discontinuation, Adherence Patterns, Hospitalizations and Costs in Non-Valvular Atrial Fibrillation (NVAF) Patients

CompletedOBSERVATIONAL
Enrollment

28,000

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

August 31, 2014

Study Completion Date

August 31, 2014

Conditions
Atrial Fibrillation
Interventions
DRUG

apixaban

DRUG

dabigatran

DRUG

rivaroxaban

DRUG

warfarin

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT02792335 - Oral Anticoagulant Discontinuation, Adherence Patterns, Hospitalizations and Costs in Non-Valvular Atrial Fibrillation (NVAF) Patients | Biotech Hunter | Biotech Hunter